Full video transcriptClick to expand
Auto-generated transcript of @alphaclubsupps's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Can you still have kids if you're on TRT?
- 0:02This is probably one of the most commonly asked questions I get second to maybe will I lose me
- 0:07barnock. Whilst it is true that when you take exogenous testosterone it shuts down your natural
- 0:13system that's testosterone and sperm production. It doesn't mean that being able to conceive is
- 0:19completely out of the question. I know loads of guys who are on TRT and have had children without any
- 0:23other intervention. That being said there is a few things that you can do to mitigate,
- 0:29lack of fertility and help yourself along the way. Two best things for this would be HCG
- 0:36and Enclomaphine and there are some other things like peptides like kispetin but the data is still a
- 0:43little bit shady around them. So do not let worries about fertility stop you from embarking on a journey
- 0:50which may just change your life. If you want to know more around these subjects or you want to know
- 0:55how to get started on TRT you can drop TRT into the comments.
TRT and fertility: what the caption gets right and glosses over
Quick answer
Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, reducing LH, FSH, and intratesticular testosterone in a way that is well documented to cause azoospermia or severe oligospermia in a significant proportion of men. HCG co-administration is supported by clinical evidence for preserving spermatogenesis during TRT, and enclomiphene has emerging evidence as an alternative that stimulates endogenous gonadotropin release. Men with fertility goals should be counseled on sperm banking before initiating TRT and referred to a reproductive endocrinologist or urologist with andrology experience.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For TRT and fertility: what the caption gets right and glosses over, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With HSDD: A Randomized Clinical Trial
Double-blind placebo-controlled crossover in 32 men where kisspeptin modulated sexual brain networks and increased penile tumescence versus placebo.
PubMed
Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial
Double-masked placebo-controlled crossover in 32 premenopausal women showing kisspeptin modulated sexual and attraction brain processing.
PubMed
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
TRT and fertility: what the caption gets right and glosses over is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "TRT and fertility: what the caption gets right and glosses over" from Alpha Club Supplements UK. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, reducing LH, FSH, and intratesticular testosterone in a way that is well documented to cause azoospermia or severe oligospermia in a significant proportion of men.
The reason this review is not generic is the source wording and the canonical claim label "trt can you still have kids while on trt yes plenty of men do so." In this clip, the useful excerpt is: "Can you still have kids if you're on TRT?" That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With HSDD: A Randomized Clinical Trial (2023), Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial (2022), and Direct comparison of intravenous kisspeptin-10, kisspeptin-54 and GnRH on gonadotrophin secretion in healthy men (2015), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, reducing LH, FSH, and intratesticular testosterone in a way that is well documented to cause azoospermia or severe oligospermia in a significant proportion of men.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, reducing LH, FSH, and intratesticular testosterone in a way that is well documented to cause azoospermia or severe oligospermia in a significant proportion of men. HCG co-administration is supported by clinical evidence for preserving spermatogenesis during TRT, and enclomiphene has emerging evidence as an alternative that stimulates endogenous gonadotropin release. Men with fertility goals should be counseled on sperm banking before initiating TRT and referred to a reproductive endocrinologist or urologist with andrology experience.
- Sperm banking before starting TRT is the most overlooked protective step and was not mentioned in this video. It is low cost relative to fertility treatments and preserves options regardless of individual response.
- Grimes et al. (2005, Lancet) reported azoospermia or severe oligospermia in the majority of men using exogenous testosterone as part of male contraceptive trials, meaning suppression is the rule, not the exception.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Sperm banking before starting TRT is the most overlooked protective step and was not mentioned in this video. It is low cost relative to fertility treatments and preserves options regardless of individual response.
- Grimes et al. (2005, Lancet) reported azoospermia or severe oligospermia in the majority of men using exogenous testosterone as part of male contraceptive trials, meaning suppression is the rule, not the exception.
- HCG co-administration is the most evidence-supported method for maintaining spermatogenesis during TRT. Hsieh et al. (2013, Journal of Urology) found it largely preserved sperm production in men on exogenous testosterone.
- Recovery of spermatogenesis after stopping TRT is not guaranteed. Liu et al. (2006, Journal of Clinical Endocrinology and Metabolism) found most men recovered within 6 to 18 months, but a subset did not return to baseline.
- Enclomiphene stimulates endogenous LH and FSH production and is a legitimate option for men who want fertility preservation, but it should be managed by a clinician with andrology or reproductive endocrinology experience.
- Kisspeptin is a research-stage compound with no established clinical protocol for fertility preservation during TRT. It should not be treated as an equivalent alternative to HCG or enclomiphene at this time.
- Any man with fertility goals considering TRT should consult a urologist or reproductive endocrinologist, not just a general TRT prescriber, before starting treatment.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @alphaclubsupps actually say?
The creator's core claim is reasonable on its face: exogenous testosterone suppresses natural testosterone and sperm production, but conception is still possible for some men on TRT, and fertility support options exist. They name HCG and enclomiphene as the two best interventions, briefly mention kisspeptin peptides, and tell viewers not to let fertility fears stop them from starting TRT.
That last line is where things get shaky. Framing TRT as a "journey which may just change your life" while downplaying fertility risk in a 60-second clip is the kind of casual optimism that can lead men to make irreversible short-term decisions. The claim that "loads of guys" conceive without any intervention is anecdotal and does real work here, softening a well-documented suppression effect that the medical literature takes seriously.
Does the science back this up?
Partially, but with important caveats the video glosses over. Exogenous testosterone reliably suppresses the hypothalamic-pituitary-gonadal (HPG) axis, reducing LH and FSH, which drives down intratesticular testosterone and sperm production. The suppression is not trivial.
A widely cited review by Grimes et al. (2005, Lancet) on testosterone as a male contraceptive found that azoospermia or severe oligospermia developed in the majority of men on exogenous testosterone, though rates varied by ethnicity and baseline sperm count. Recovery of spermatogenesis after stopping TRT can take six months to over two years, and in some men it does not fully recover (Liu et al., 2006, Journal of Clinical Endocrinology and Metabolism). The idea that the fertility impact is "massively overblown" is not well supported by the reproductive endocrinology literature. It is a real, well-documented effect, not a myth.
That said, co-administration of HCG to maintain intratesticular testosterone and preserve spermatogenesis does have clinical support. Hsieh et al. (2013, Journal of Urology) found that HCG co-treatment largely preserved sperm production in men on exogenous testosterone. That part of the video is on solid ground.
What did they get wrong (or right)?
They got the mechanism right: exogenous testosterone does suppress the natural system, and they said so clearly. Credit for that. HCG as a co-treatment is well supported, and naming it as a primary tool is accurate clinical guidance. Enclomiphene, a selective estrogen receptor modulator, also has reasonable evidence for stimulating endogenous LH and FSH in men, making it a legitimate option, particularly for men who want to preserve or restore fertility without going off testosterone entirely.
Where the video goes wrong is in framing the suppression as something that is "massively overblown." The data does not support that characterization. Azoospermia rates on exogenous testosterone are high enough that multiple testosterone-based male contraceptive trials used this suppression as the mechanism of action. Telling men not to let fertility fears stop them from starting TRT, without emphasizing that baseline sperm banking is a practical, low-cost protective step, is an omission that matters. On kisspeptin, the creator correctly notes that data is limited, which is accurate. It should not be treated as an established fertility-preservation tool.
What should you actually know?
If fertility matters to you now or in the next few years, the practical steps are straightforward and the video does not cover them adequately. Sperm banking before starting TRT is inexpensive relative to fertility treatments and gives you options regardless of how your body responds. This should be the first recommendation anyone gives, and it was not mentioned here.
HCG co-administration is the most evidence-backed approach for preserving spermatogenesis during TRT. Enclomiphene is a reasonable alternative or adjunct, particularly for men who prefer to avoid injectable HCG. Both require a prescribing clinician who understands reproductive endocrinology, not just hormone optimization. Recovery of fertility after stopping TRT is not guaranteed and the timeline is unpredictable. Liu et al. (2006, Journal of Clinical Endocrinology and Metabolism) reported that while most men recovered sperm production within 6 to 18 months after discontinuation, a subset did not recover to baseline. Age, duration of TRT use, and baseline fertility status all affect outcomes. Anyone making decisions based on what "loads of guys" have experienced is working with the wrong dataset.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Alpha Club Supplements UK · TikTok creator
1.4K views on this video
Can you still have kids while on TRT? 👶💉 Yes, plenty of men do. Some conceive with no extra support at all, some need a little help, but the idea that starting TRT automatically means no fertility is massively overblown 📉 That said, if having kids matters to you, don’t leave it to chance. TRT can reduce the signals that support sperm production, so going in with a proper plan is always the smarter move 🧠 This is where things like HCG or enclomiphene can be useful. They help support the
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about sperm banking before starting trt?
Sperm banking before starting TRT is the most overlooked protective step and was not mentioned in this video. It is low cost relative to fertility treatments and preserves options regardless of individual response.
What does the video say about grimes et al. (2005, lancet) reported azoospermia?
Grimes et al. (2005, Lancet) reported azoospermia or severe oligospermia in the majority of men using exogenous testosterone as part of male contraceptive trials, meaning suppression is the rule, not the exception.
What does the video say about hcg co-administration?
HCG co-administration is the most evidence-supported method for maintaining spermatogenesis during TRT. Hsieh et al. (2013, Journal of Urology) found it largely preserved sperm production in men on exogenous testosterone.
What does the video say about recovery of spermatogenesis after stopping trt?
Recovery of spermatogenesis after stopping TRT is not guaranteed. Liu et al. (2006, Journal of Clinical Endocrinology and Metabolism) found most men recovered within 6 to 18 months, but a subset did not return to baseline.
What does the video say about enclomiphene stimulates endogenous lh?
Enclomiphene stimulates endogenous LH and FSH production and is a legitimate option for men who want fertility preservation, but it should be managed by a clinician with andrology or reproductive endocrinology experience.
What does the video say about kisspeptin?
Kisspeptin is a research-stage compound with no established clinical protocol for fertility preservation during TRT. It should not be treated as an equivalent alternative to HCG or enclomiphene at this time.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Not medical advice. This video was made by Alpha Club Supplements UK, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.